Phastar has been shortlisted for the Excellence in Clinical Trial Management category at the Fierce CRO Awards 2025. The award recognizes organizations that are redefining trial delivery through innovation, efficiency, and improved oversight.
Our entry highlighted the impact of Phastar’s Clinical Intelligence platform, developed to support real-time oversight across complex trials by integrating operational, statistical, medical, and risk-based data into a single, unified environment. With dashboards and tools tailored for medical monitors, data managers, statisticians, and operational teams, the platform delivers actionable insights that support faster, smarter decision-making.
To date, the platform has supported more than 100 clinical trials across over 20 therapeutic areas. Key benefits reported include improved oversight, reduced timelines, enhanced collaboration, and more effective risk mitigation. In one example, a global biotech company saw a 50% reduction in data review time and 75% faster medical monitoring activities.
This shortlisting reflects the hard work and dedication of the Phastar team and our collaborators who continue to drive innovation in trial delivery. We are pleased to be recognized alongside other organizations committed to advancing clinical research.
